In Vivo Star Anti-Mouse CD16/CD32 Antibody
英诺赛图(InnoCyto)的 In Vivo Star Anti-Mouse CD16/CD32 Antibody(克隆 2.4G2-m2a) 为鼠源 IgG2a Kappa 抗体,靶向 CD16/32(别名 Fcγ R III/II 等)。提供 1 mg、5 mg、25 mg 规格,目录价 ¥1,085 起,仅供科研使用(RUO)。
01产品图片

02产品简介
英诺赛图(InnoCyto)的 In Vivo Star Anti-Mouse CD16/CD32 Antibody(克隆 2.4G2-m2a) 为鼠源 IgG2a Kappa 抗体,靶向 CD16/32(别名 Fcγ R III/II 等)。提供 1 mg、5 mg、25 mg 规格,目录价 ¥1,085 起,仅供科研使用(RUO)。
03产品介绍
规格与货号
510901 | 1 mg | ¥1,085
510902 | 5 mg | ¥2,712
510903 | 25 mg | ¥7,458
511001 | 1 mg | ¥1,085
511002 | 5 mg | ¥2,712
511003 | 25 mg | ¥7,458
511101 | 1 mg | ¥1,085
511102 | 5 mg | ¥2,712
511103 | 25 mg | ¥7,458
511201 | 1 mg | ¥6,102
511202 | 5 mg | ¥14,916
511203 | 25 mg | ¥40,002
511301 | 1 mg | ¥1,085
511302 | 5 mg | ¥2,712
511303 | 25 mg | ¥7,458
511401 | 1 mg | ¥1,085
511402 | 5 mg | ¥2,712
511403 | 25 mg | ¥7,458
Product Details
Application|ELISA, WB, Flow cytometry, IHC, ICC, animal model study
Product Description|In vivo Grade Recombinant Anti-mouse CD16/CD32 Monoclonal Antibody
Regulatory Status|RUO
Endotoxin
Storage Conditions|4ºC
Recommended Usage|This product is suitable for in vivo animal use. Optimal amounts need to be determined empirically for each experiment.
See All Formats|Clone 2.4G2-m2a
Background Information
CD16 (FcγRIII) and CD32 (FcγRII) are receptors for the Fc region of immunoglobulin G (IgG) and are key mediators of antibody-dependent immune responses. They are expressed on a variety of immune cells, including natural killer (NK) cells, monocytes, macrophages, neutrophils, dendritic cells, and B cells. By linking antibody recognition to cellular effector functions, CD16 and CD32 serve as critical bridges between humoral immunity and innate immune mechanisms.
Structurally, both CD16 and CD32 are members of the immunoglobulin superfamily but differ in affinity, signaling capacity, and cellular distribution. CD16 exists in two main forms: CD16a (FcγRIIIa), a transmembrane receptor expressed on NK cells and myeloid cells that associates with signaling adaptor chains containing immunoreceptor tyrosine-based activation motifs (ITAMs), and CD16b (FcγRIIIb), a glycosylphosphatidylinositol (GPI)-anchored receptor expressed primarily on neutrophils. CD32 includes several isoforms, most notably CD32a (FcγRIIa) and CD32b (FcγRIIb), which are transmembrane receptors with distinct cytoplasmic signaling motifs.
The ligands for CD16 and CD32 are IgG antibodies bound to antigen, forming immune complexes. CD16 primarily binds IgG1 and IgG3 and is a major mediator of antibody-dependent cellular cytotoxicity (ADCC), particularly by NK cells. CD32a transmits activating signals via an intrinsic ITAM, promoting phagocytosis, cytokine release, and inflammatory responses. In contrast, CD32b contains an immunoreceptor tyrosine-based inhibitory motif (ITIM) in its cytoplasmic tail and functions as a negative regulator, dampening B cell receptor and Fc receptor signaling to maintain immune balance.
Altered expression or function of CD16 and CD32 is implicated in a range of diseases. In autoimmune disorders such as systemic lupus erythematosus and rheumatoid arthritis, dysregulated Fcγ receptor signaling contributes to immune complex–mediated inflammation and tissue damage. In infectious diseases, these receptors are essential for efficient clearance of antibody-opsonized pathogens. Genetic polymorphisms in CD16 and CD32 influence IgG binding affinity and are associated with variability in susceptibility to disease and responses to antibody-based therapies.
Therapeutically, CD16 and CD32 are central to the mechanism of action of many monoclonal antibody drugs. Engagement of CD16 on NK cells is critical for ADCC-mediated tumor cell killing, making it a key determinant of antibody efficacy in cancer therapy. Engineering antibodies to enhance Fcγ receptor binding is an active area of drug development. Conversely, targeting inhibitory CD32b signaling is being explored to modulate immune responses in autoimmunity and to improve vaccine efficacy. Together, CD16 and CD32 represent pivotal regulators of antibody-driven immunity with broad clinical relevance.
Data Sheets
Cat # Size Price Quantity 5110011 mg Add to Cart5110025 mg Add to Cart51100325 mg Add to Cart
04完整参数表
参数由厂商资料整理,采购前请以最终报价单与技术协议为准。
05荣誉与资质
该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。
- 营业执照未上传
- 品牌授权未上传
- 产品检测报告未上传
- 会员身份
- 收费会员
- 经营身份
- 原厂
- 成立年份
- 2020 年
- 所在地
- 上海
- 收录条目
- 1865 个
- 平台核验
- 平台代管
06品牌与供应商
InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。
品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。
07同类条目
同一子类内的条目才具备可比性。跨子类比较参数通常没有意义。
08同品牌其他条目
上海英诺赛图 在本目录共 1865 个条目,除本条外还有:
科研在线(TeleVM). In Vivo Star Anti-Mouse CD16/CD32 Antibody(511001)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/in-vivo-star-anti-mouse-cd16-cd32-antibody-511001.html.
TeleVM. (2026, November 12). In Vivo Star Anti-Mouse CD16/CD32 Antibody(511001). 产品目录. https://www.suprotek.cn/products/item/in-vivo-star-anti-mouse-cd16-cd32-antibody-511001.html
@misc{biocsp_item_in_vivo_star_anti_mouse_cd16_cd32_antibody_511001,
title = {In Vivo Star Anti-Mouse CD16/CD32 Antibody(511001)},
author = {{科研在线}},
year = {2026},
howpublished = {产品目录},
note = {更新于 2026-11-12,产品目录},
url = {https://www.suprotek.cn/products/item/in-vivo-star-anti-mouse-cd16-cd32-antibody-511001.html}
}
GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。
许可:CC BY-NC 4.0 · 转载注明来源